Literature DB >> 24964700

Sensitivity analysis for handling uncertainty in an economic evaluation.

Supon Limwattananon.   

Abstract

To meet updated international standards, this paper revises the previous Thai guidelines for conducting sensitivity analyses as part of the decision analysis model for health technology assessment. It recommends both deterministic and probabilistic sensitivity analyses to handle uncertainty of the model parameters, which are best represented graphically. Two new methodological issues are introduced-a threshold analysis of medicines' unit prices for fulfilling the National Lists of Essential Medicines' requirements and the expected value of information for delaying decision-making in contexts where there are high levels of uncertainty. Further research is recommended where parameter uncertainty is significant and where the cost of conducting the research is not prohibitive.

Mesh:

Year:  2014        PMID: 24964700

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  4 in total

1.  Cost-effectiveness of coronary artery bypass graft and percutaneous coronary intervention compared to medical therapy in patients with coronary artery disease: a systematic review.

Authors:  Saeed Sheikh Gholami; Farbod Ebadi Fard Azar; Aziz Rezapour; Masih Tajdini
Journal:  Heart Fail Rev       Date:  2019-11       Impact factor: 4.214

2.  Cost-effectiveness of B-type natriuretic peptide-guided care in patients with heart failure: a systematic review.

Authors:  Abdosaleh Jafari; Aziz Rezapour; Marjan Hajahmadi
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

3.  Economic Evaluation of Human Rotavirus Vaccine in Thailand.

Authors:  Surasak Saokaew; Wasana Prasitsuebsai; Gyneth Lourdes Bibera; Kirati Kengkla; Xu-Hao Zhang; Kyu-Bin Oh; Christa Lee
Journal:  Infect Dis Ther       Date:  2019-06-13

4.  The cost utility and budget impact of adjuvant racecadotril for acute diarrhea in children in Thailand.

Authors:  Tamlyn Anne Rautenberg; Ute Zerwes
Journal:  Clinicoecon Outcomes Res       Date:  2017-07-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.